Product Information
PREGABALIN 200 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0593 per EA under NDC 31722061505. Its NADAC has been published 198 times since Dec 21, 2022.
FDA first approved this application on Oct 8, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722061505
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA206912FDA Approved
10/8/2019
TE Code
AB
On Market Since
10/8/2019
Price Statistics
The NADAC for PREGABALIN 200 MG CAPSULE has been published 198 times since Dec 21, 2022, and over the history we have for it it has declined 34.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0593 per EA |
|---|---|
| All-time high | $0.1002 (Sep 13, 2023) |
| All-time low | $0.0552 (Nov 20, 2024) |
| 52-week high | $0.0650 |
| 52-week low | $0.0564 |
| Median price | $0.0693 |
| Average price | $0.0707 |
| Largest weekly change | +25.7% (Aug 21, 2024) |
| Weeks tracked | 198 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pregabalin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREGABALIN 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 200 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.0593 per EA (NDC 31722061505), effective Sep 30, 2026.
How has the price of PREGABALIN 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PREGABALIN 200 MG CAPSULE has declined 34.4%. It has been tracked across 198 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for PREGABALIN 200 MG CAPSULE?
Since Dec 21, 2022, the NADAC for PREGABALIN 200 MG CAPSULE has ranged from a low of $0.0552 (Nov 20, 2024) to a high of $0.1002 (Sep 13, 2023), with a median of $0.0693 per EA.
Are there cheaper alternatives to PREGABALIN 200 MG CAPSULE?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 200 MG CAPSULE, is $0.0593 per EA — about 0% below PREGABALIN 200 MG CAPSULE.
Who manufactures PREGABALIN 200 MG CAPSULE?
PREGABALIN 200 MG CAPSULE (NDC 31722061505) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.